Me za a yi idan jini ba ya taru da sauƙi?


Marubuci: Magaji   

Matsalar da ke tattare da zubar jini na iya faruwa ne sakamakon matsalar zubar jini, rashin daidaituwar platelets da sauran abubuwa. Ana ba da shawarar cewa marasa lafiya su fara tsaftace raunin, sannan su je asibiti don a duba su a kan lokaci. Dangane da dalilin, za a iya yin ƙarin jini ga platelets, ƙarin sinadarin coagulation da sauran hanyoyin magani a ƙarƙashin jagorancin likita.
1. Tsaftace raunin: Jini ba shi da sauƙin taruwa kuma raunin zai ci gaba da zubar jini. Ya kamata majiyyaci ya fara tsaftace raunin a ƙarƙashin jagorancin likita sannan ya yi amfani da iodophor don tsaftace raunin don guje wa kamuwa da ƙwayoyin cuta.
2. Zubar da ƙwayoyin platelet: Idan jinin majiyyaci bai taru ba saboda ƙarancin ƙwayoyin platelet, ana iya yin ƙarin ƙwayoyin platelet a ƙarƙashin jagorancin likita. Bayan an yi ƙarin, ya kamata a lura da alamun majiyyacin don guje wa wasu mummunan sakamako waɗanda ka iya cutar da lafiyar majiyyacin.
3. Ƙarin abubuwan da ke ƙara yawan jini: Idan majiyyaci ya samu matsala wajen fitar da jini, ana iya yi masa magani ta hanyar amfani da ƙarin abubuwan da ke ƙara jini a jini da kuma ƙarin abubuwan da ke ƙara jini a ƙarƙashin jagorancin likita.
Bugu da ƙari, ana ba da shawarar marasa lafiya su yi amfani da magungunan kashe ƙwayoyin cuta don hana kamuwa da cuta kamar yadda likitansu ya umarta. Idan mara lafiyar ya ji ba shi da lafiya, ana ba da shawarar a je asibiti don a duba shi a kan lokaci kuma a magance shi bisa ga dalilin da ya sa a ƙarƙashin jagorancin likita don guje wa mummunan rashin lafiya da cutar da ke barazana ga lafiyar majiyyaci.
Kamfanin SUCCEEDER na Beijing a matsayin daya daga cikin manyan kamfanonin da ke cikin kasuwar gano cututtukan thrombosis da hemostasis ta kasar Sin, ya samu kwarewa a fannin bincike da ci gaba, samarwa, tallace-tallace da ayyuka, yana samar da na'urorin tantance jini da reagents, masu nazarin rheology na jini, masu nazarin ESR da HCT, masu nazarin platelet tare da ISO13485, takardar shaidar CE da kuma FDA da aka jera.